Discuss as:

Pharmacies deter teens from Plan B, study shows

A new study finds that pharmacies often offered inaccurate information when they thought 17-year-old girls were seeking emergency contraception such as Plan B One-Step.

 Even though it’s legal for 17-year-olds to get the so-called morning-after pill, a new study shows that pharmacy employees often dole out the wrong information, telling the teens they’re not allowed to have the drug.

An undercover survey found that many of the pharmacies that told girls they were too young to get emergency contraception offered correct information when a doctor called seeking the pill for a 17-year-old patient, according to a report in the latest issue of the journal Pediatrics.

“I was shocked that 19 percent of 17-year-olds were told they couldn’t get the medication at all,” said Dr. Tracey Wilkinson, the study’s lead author and a general pediatrics fellow at Boston Medical Center/Boston University School of Medicine.

“That’s like one in five. And I think if you told an adolescent once that she couldn’t get the medication, she probably wouldn’t call another pharmacy. It would be the end of her attempts.”

Wilkinson’s study was aimed at evaluating the real-world availability of Plan B One-Step and other emergency contraception drugs, which are available without prescription to girls and women starting at age 17. Girls younger than 17 require prescriptions to obtain the medication.

Proponents say that using emergency contraception could prevent half of all unplanned teen pregnancies. Each year in the U.S., nearly 750,000 girls ages 15 to 19 become pregnant, and about 85 percent of those are unplanned, according to the Guttmacher Institute.

For the new study, researchers posing as either a 17-year-old girl or a doctor seeking help for a 17-year-old girl called every pharmacy in each of five U.S. cities asking about the availability and accessibility of emergency contraception.

All callers asked questions from a script. The first question was whether the pharmacy had the medication in stock -- 80 percent of the 943 pharmacies said they did. Next, the researcher posing as a teen asked if she could get the drug, while the researcher posing as the doctor of a 17-year-old patient asked if the patient could get the medication.

There was a huge disparity between the answers given to the teens and those offered to the physicians, with 19 percent of the 17-year-olds being told that they couldn’t get it under any circumstances, compared with only 3 percent of the physicians.

The next question was asked only by teen callers who had been told a 17-year-old could get the morning-after pill: “My friends said there is an age rule [regarding access without a prescription] -- do you know what it is?”

Pharmacy employees answered that incorrectly 43 percent of the time.

The researchers can’t say anything for sure about the motivation behind the misinformation because that wasn’t part of the experiment. It might be partly explained by the fact that the doctors in the study tended to get actual pharmacists on the phone while “teens” often got lower-level pharmacy employees who might have been less informed about the FDA rules. The researchers found that, in general, teens were put on hold more often and that they spoke less often to pharmacists.

It’s also possible that the misinformation was given on purpose by pharmacy employees who didn’t want to dole out morning-after pills to 17-year-olds.

“It’s a controversial topic," Wilkinson said. “It shouldn’t be, but it is. And anything with controversy heightens a person’s personal beliefs.”

Indeed, the topic has been so controversial that it forced a showdown in December over whether to make the drug available without prescription to girls younger than 17. Health and Human Services Secretary Kathleen Sebelius invoked her authority to overrule the recommendation of a Food and Drug Administration center and the agency's head, Commissioner Margaret Hamburg, who supported the move.

Wilkinson hopes the new study will raise awareness about the problem of pharmacists dispensing inaccurate information.

“This was disappointing,” she said. “I hope this study will instigate some sort of change on all fronts, for teenagers, pharmacists, staff and also clinicians.”       

Related stories:

Plan B won't be available OTC to younger teens, HHS says

Bioethicist: Plan B ruling trumps good science with bad policy